Cyclosporin a treatment of Behçet's disease
Büsch, R.; Ruzicka, T.; Donhauser, G.
Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 41(4): 229-231
1990
ISSN/ISBN: 0017-8470 PMID: 2358347 Document Number: 353426
We report on an Italian patient with severe mucocutaneous and arthritic manifestations of Behçet's disease. Monotherapy with cyclosporin A led to a complete remission. The therapeutic efficiency could be verified by relapse after discontinuation of treatment and a second remission after its reintroduction.
Document emailed within 1 workday
Related Documents
Shibata, K.; Takeuchi, M.; Kikuchi, M.; Kobayashi, I.; Maruyama, S. 1991: A case of Behçet's disease associated with myopathy during cyclosporin treatment Rinsho Shinkeigaku 31(8): 847-852Cantini, F.; Salvarani, C.; Niccoli, L.; Padula, A.; Arena, A.I.; Bellandi, F.; Macchioni, P.; Olivieri, I. 1999: Treatment of thrombophlebitis of Behçet's disease with low dose cyclosporin a Clinical and Experimental Rheumatology 17(3): 391-392
Kotake, S.; Ichiishi, A.; Kosaka, S.; Yoshikawa, K.; Minagawa, R.; Matsuda, H. 1992: Low dose cyclosporin treatment for ocular lesions of Behçet's disease Nippon Ganka Gakkai Zasshi 96(10): 1290-1294
Chams-Davatchi, C.; Shizarpour, M.; Davatchi, F.; Shahram, F.; Chams, H.; Nadji, A.; Jamshidi, A.R. 2003: Extensive pyoderma gangrenosum-like lesion in two cases of Behçet's disease, responding only to cyclosporin Advances in Experimental Medicine and Biology 528: 337-338
Urayama, A.; Sakai, F.; Imai, Y. 1973: Behçet's disease associated with vascular lesions (Angio-Behçet's syndrome) (authors' transl) Nippon Ganka Gakkai Zasshi 77(9): 1461-1467
Gasparini, G.; Sambvani, N.; Contini, D.; Brigonzi, A. 1985: Use of colchicine in the treatment of Behçet's disease Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 120(2): 159-163
Gunn, H.C.; Ryffel, B. 1986: Successful treatment of autoimmunity in (NZB X NZW)F1 mice with cyclosporin and (Nva2)-cyclosporin: II. Reduction of glomerulonephritis Clinical and Experimental Immunology 64(2): 234-242
Namba, K. 2010: Infliximab treatment for Behçet's disease--beginning of the biological drug era Nippon Ganka Gakkai Zasshi 114(2): 85-86
Zouboulis, C.C.; Orfanos, C.E. 1998: Treatment of Adamantiades-Behçet disease with systemic interferon alfa Archives of Dermatology 134(8): 1010-1016
Shimizu, T. 1977: Refractory diseases. 2. Physiopathology, diagnosis and treatment of Behcet's disease Nursing Technique 23(8): 137-148
Cuchacovich, M.; Gatica, H.; Verdaguer, J.I.; Carreño, M.A.; Villarroel, F.; Verdaguer, J. 1999: Treatment of non infectious ocular inflammatory disease with low doses of cyclosporin a Revista Medica de Chile 127(3): 277-285
Kaouel, K.; Mechergui, S.; Ben Mrad, I.; Denguir, R.; Kalfat, T.; Khayati, A. 2013: Endovascular treatment of an aneurysm of the abdominal aorta secondary to Behcet's disease La Tunisie Medicale 91(8-9): 559-561
Kuniyoshi, Y.; Koja, K.; Miyagi, K.; Uezu, T.; Yamashiro, S.; Arakaki, K.; Mabuni, K.; Senaha, S. 2002: Surgical treatment of Budd-Chiari syndrome induced by Behcet's disease Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia 8(6): 374-380
Testini, M.; Verzillo, F.; Paradiso, V.; D'agostino, D.; Ferlan, G.; Caruso, G. 1996: The surgical treatment of vascular and gastrointestinal implications in Behçet disease. Report of four cases Panminerva Medica 38(3): 185-189
Evereklioglu, C. 2007: Inclusion and exclusion criteria, methodological flaw and ethical concepts for the treatment of patients with ocular Behçet disease Dermatology Online Journal 13(3): 35
Quartuccio, L.; De Marchi, G.; Scott, C.A.; Ferraccioli, G.; Beltrami, C.A.; De Vita, S. 2007: Treatment of inclusion body myositis with cyclosporin-A or tacrolimus: successful long-term management in patients with earlier active disease and concomitant autoimmune features Clinical and Experimental Rheumatology 25(2): 246-251
Schirmer, M.; Calamia, K.T.; O'Duffy, J.D. 1999: Is there a place for large vessel disease in the diagnostic criteria of Behçet's disease? Journal of Rheumatology 26(12): 2511-2512
Kanamaru, A.; Takemoto, Y.; Kakishita, E.; Dohy, H.; Kodera, Y.; Moriyama, Y.; Shibata, A.; Kasai, M.; Katoh, S.; Saitoh, H. 1995: FK506 treatment of graft-versus-host disease developing or exacerbating during prophylaxis and therapy with cyclosporin and/or other immunosuppressants. Japanese FK506 BMT Study Group Bone Marrow Transplantation 15(6): 885-889
Inanc, N.; Mumcu, G.; Birtas, E.; Elbir, Y.; Yavuz, S.; Ergun, T.; Fresko, I.; Direskeneli, H. 2005: Serum mannose-binding lectin levels are decreased in behcet's disease and associated with disease severity Journal of Rheumatology 32(2): 287-291
Zhang, F.; Su, M.; Zhang, B.; Dong, Y.; Li, P. 2015: Clinical features and disease activity index of Behçet's disease Zhonghua yi xue za zhi 95(31): 2547-2550